Tokyo, Japan

Sadao Tamamura


Average Co-Inventor Count = 3.7

ph-index = 5

Forward Citations = 47(Granted Patents)


Company Filing History:


Years Active: 1983-1989

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Sadao Tamamura: Innovator in Biologically Active Substances

Introduction

Sadao Tamamura is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of biologically active substances, holding a total of 5 patents. His work focuses on the extraction and production of compounds that have potential therapeutic applications.

Latest Patents

Tamamura's latest patents include a process for producing a biologically active substance derived from maize (Zea mays Linne). This substance has a specific elemental analysis and is capable of inhibiting the formation of IgE antibodies while promoting IgG and IgM antibodies. It exhibits various biological activities, including interferon-inducing activity and anti-tumor activity, making it a promising candidate for treating conditions such as asthma, rhinitis, and immunological insufficiency. Another significant patent involves a process for producing interferon inducers from various plant tissues. This process allows for the extraction of water-soluble interferon inducers, which have potential applications in preventing and treating viral infections in both humans and animals.

Career Highlights

Throughout his career, Sadao Tamamura has worked with esteemed institutions, including the Kitasato Institute. His research has contributed to advancements in the understanding and application of biologically active substances.

Collaborations

Tamamura has collaborated with notable colleagues such as Yasuhiko Kojima and Seishi Konno. Their combined expertise has furthered research in the field of biologically active compounds.

Conclusion

Sadao Tamamura's innovative work in the extraction and production of biologically active substances has the potential to impact various medical fields significantly. His contributions continue to pave the way for advancements in therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…